Corporate governance

ContextVision AB is registered in Sweden and is controlled by its Articles of Association according to the Companies Act in Sweden and Swedish law.

Since 1997, the company is listed on the Oslo Stock Exchange under the ticker COV and operates under Oslo Stock Exchange rules and regulations. ContextVision complies with all applicable guidelines and procedures stipulated in the Norwegian Code of Practice for Corporate Governance. The deviations are explained in the Corporate Governance report (extracted from the Annual Report 2014).
ContextVision AB is registered in Sweden and is controlled by its Articles of Association according to the Companies Act in Sweden and Swedish law.

Since 1997, the company is listed on the Oslo Stock Exchange under the ticker COV and operates under Oslo Stock Exchange rules and regulations. ContextVision complies with all applicable guidelines and procedures stipulated in the Norwegian Code of Practice for Corporate Governance. The deviations are explained in the Corporate Governance report (extracted from the Annual Report 2014).

Board of directors

Board of directors

Board of directors

Erik Danielsen

Erik Danielsen

Chairman

Danielsen (born 1963) was elected to the Board in 2004 and appointed chairman in 2010. He holds an MBA in Finance and Swiss Business Law from the University of Fribourg in Switzerland, 1987. Since 1993, he has been acting as an independent health care analyst and consultant, advising both young growth companies as well as private and industrial investors on a variety of subjects including company evaluations, equity financing and operational communication strategies. Mr. Danielsen continues to support the activities of Bridge Relations Ltd and Analitika SA, two consulting companies he originally founded. In mid 2012 he assumed the role as CEO of Spring Medical SA, a marketer of next-generation medical device technologies, predominantly in Switzerland and Austria. Mr. Danielsen is a co-founder of Spring Medical, which has its corporate headquarters in Mezzovico, Switzerland. Danielsen previously worked as an equity strategist and analyst for Credit Suisse in Zurich and Credit Suisse First Boston in New York. Danielsen is a member of the following companies: Analitika SA, Spring Medical SA adn Bridge Realtions Ltd.

As of December, 2016, he owns 4,500 shares in ContextVision through ORCA Ventures AG, a closely held investment company.
Martin Hedlund

Martin Hedlund

Hedlund (born 1952) is one of the founders of ContextVision AB. He finished his M.Sc. degree of Technology followed by further studies and research in image processing and GOP® theory at Linköping University. Hedlund was R&D and Site Manager in Linköping until 1999. Since then he has served as CTO, focusing on strategic product and business development.

He has been a member of the Board since the company went public in 1997.

As of December 31, 2016, Hedlund owns 831,666 shares (10,7%) in ContextVision and he is a board member of the wholly owned Yakiva AB and Slaka Invest AB.
Magne Jordanger

Magne Jordanger

Jordanger (born 1953) was elected to the Board in 2002. Jordanger holds a BA degree from IMD Lausanne, Switzerland 1981. Throughout his career as an owner-manager, Jordanger has operated within various international industries and is presently the chairman or member of the following boards: Autogruppen AS, Autolink AS, Konsmo Fabrikker AS, BNS Holding AS and Creditsafe NV.

As of December 31, 2016, Jordanger controls 2,248,750 (29,1%) shares through the company Monsun AS.
Karin Bernadotte

Karin Bernadotte

Bernadotte (born 1963) was elected to the Board in 2011. She holds a M.Sc. degree in Pharmacy from the University of Uppsala. Bernadotte has more than 20 years of experience from various marketing positions, including international positions at the healthcare ones at the healthcare company MSD/Merck. Between 2006 and 2011 she served as Managing Director of MSD Sweden. Since October 2011, Bernadotte holds the position Assoc VP Public Policy and Corpaorate Responsibility Europe and Canada for MSD/Merck.

As of December 31, 2016, Bernadotte holds 6,500 shares in ContextVision.
Sven Günther-Hanssen

Sven Günther-Hanssen

Günther-Hanssen (born 1954) is one of the founders of ContextVision and he has previously served as CEO for the company, as well as board member. He was re-elected to the board in 2011. During later years Günther-Hanssen has acted as a venture capitalist and been involved in a number of start-up companies in the medical, industrial and financial sectors in the capacity of investor as well as board member. He holds a M.Sc. degree in Industrial Engineering from the Institute of Technology at Linköping University. Günther-Hanssen is a board member of wholly owned Skyhook AB.

As of December 31, 2016, Günther-Hanssen holds 851,667 shares (11%) in the company.

Management

Anita Tollstadius

Anita Tollstadius

Chief Executive Officer

Tollstadius became CEO of ContextVision in September 2010, former member of the company board of directors. Tollstadius has held numerous management and organizational development roles in global businesses within life science during her thirty-year career. In addition to serving on the ContextVision board of directors between 2008 and 2010, Tollstadius has counseled other global medical technology companies on matters such as product research and development, production and communications. She holds a M.B.A. from the Stockholm School of Economics and a M.Sc. in Pharmacy from Uppsala University.

Anita Tollstadius owns 10.000 shares in the company, through 100% owned Tollstadius & Co AB.
Martin Hedlund

Martin Hedlund

Chief Technical Officer

Hedlund is one of the founders of ContextVision AB. He acquired his M.Sc. degree in Technology, followed by further studies and research in image processing and GOP® theory, at Linköping University. Hedlund was R&D and Site Manager in Linköping until 1999. Since then he has served as CTO, focusing on strategic product and business development. He has also been a member of the Board of Directors since the company went public in 1997.

Hedlund owns 831,666 shares (10,7%) in ContextVision.
Ann-Charlotte Linderoth

Ann-Charlotte Linderoth

Chief Financial Officer

Linderoth holds a Bachelor of Science in Business Administration and Economics from the University of Stockholm, and she has a 20-year career from different financial positions, mostly in the field of medical devices. Linderoth joined ContextVision in 2011 as Financial Officer, and took the new position from April 15, 2015.
Fredrik Palm

Fredrik Palm

Vice President OEM Business

Palm, Vice President OEM Business, joined ContextVision in January 2012. Palm has 15 years of experience within international life science business. After many years at Waters Corporation, he moved on to several sales and marketing positions at medical device companies, focusing on international expansion. His experience covers international sales, marketing and business development as well as concepts for value based communication. Palm has complemented his engineer background with studies in business management and strategic marketing.
Eskil Larsson

Eskil Larsson

Director of Special Projects

Larsson, Director of Special projects, joined ContextVision in 2011. Larsson has 36 years of industrial experience, mainly from the medical field. He has been R&D Manager and Marketing Manager at Siemens-Elema AB as well as CEO at AF Industrial Technology and Novator AB. At Siemens-Elema he handled the transfer of Mammography from Germany to Sweden and the development of the new Mammography system. Larsson has an M.Sc. in Electrical Engineering and has taken several management courses.
Arto Järvinen

Arto Järvinen

Director of Research & Development

Järvinen joined ContextVision in 2011, for the second time. He first joined the company in 1984, shortly after it was founded, having just majored in image processing at the Linköping and Stanford universities. Three years later, he left to work for the Swedish Attaché of Science and Technology in San Francisco. Since then, his career has included various management and consulting positions, such as management consultant at a global management consultancy, chief quality officer for a global PACS company and managing director for a medical device company. Järvinen’s expertise includes system development methods, operational excellence, medical device regulations and management of high-tech companies in general.
Lena Kajland-Wilén

Lena Kajland Wilén

Director of Business Unit Digital Pathology

Kajland Wilén is Director of Business Unit Digital Pathology at ContextVision AB since February 2015. Kajland Wilén has 25 years of experience within international life science business. Her marketing and business expertise was excellenced during many years at Pharmacia Ophthalmics. Thereafter she headed the marketing function within Aerocrine AB for a decade and for MicroDose mammography within Philips Healthcare for a couple of years. Lately she has worked as a marketing and business development consultant. Kajland Wilén holds a Master in Chemical Engineering from the Royal Institute of Technology and a DIHM in Marketing economics from Business School IHM.

Auditors

External auditors are elected at the Annual General Meeting for a period of one year. At the Annual General Meeting 2016, Ernst & Young, with acting auditor Erik Sandström, were reelected as auditor for the coming year.

Downloads

Corporate Governance (pdf)
Articles of Association (pdf)
Available in Swedish only

Investors contact

For investors information and/or inquiries, please contact
Anita Tollstadius, CEO